The use of bold is to highlight, emphatically endorse and/or draw attention to an important point. Dr Doug Wilson highlighted six sentences in bold in the Chairman's December Update. The takeaway points were;
- The unique assets and skills of Phylogica have therefore been recognized by two of the largest and most highly regarded drug companies in the world [Roche and AstraZeneca].
- The Phylogica team has found a number of these entirely new [cell penetrating peptide] drug carriers.
- This has been a hugely successful collaboration, such that the UK team [MRC Hutchison Research Centre] is now exploring fresh and expanded commercial opportunities with Phylogica.
- Here the collaboration works to the strengths of both parties where Phylogica indentifies the new drug leads and MedImmune [US biotech arm of AstraZeneca] does the bacterial testing and the clinical studies.
- Another new partnership [TBA ASAP] will further demonstrate the Phylogica magic, as its engine is put to a quite distinct use in another very serious disease.
- Rather, [the staff of Phylogica] brings to the table an increasingly confident and 'Can Do' attitude based on their growing track record of solving very tough problems.
If Wilson has properly observed the literary rules for the use of bold, there is a growing internal confidence that Phylogica is becoming a 'significant international player in the exciting field of peptide drug discovery'. Apparently, a confidence which several Big Pharma companies are in complete agreement.
PYC Price at posting:
4.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)